EN
Edward Nash Canaccord Genuity Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
25
Avg Return
Past Year
Past Year
8.5%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
86.2%
Neutral
13.8%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Hold
Downgraded
| $14 |
1%
upside
| 2 | +48% |
0
%
| 8 Jan ‘26 19 hours ago |
|
|
|
Buy
Maintained
| $99 |
171%
upside
| 6 | +2.4% |
0
%
| 2 Jan ‘26 6 days ago |
|
|
|
Buy
Initiated
| $25 |
982%
upside
| 1 | +3.6% |
0
%
| 18 Dec ‘25 21 days ago |
|
|
|
Buy
Maintained
| $587 |
6%
upside
| 4 | +15% |
0
%
| 13 Nov ‘25 1 month ago |
|
|
|
Buy
Maintained
| $107 |
238%
upside
| 2 | -2.9% |
0
%
| 12 Nov ‘25 1 month ago |
|
|
|
Hold
Downgraded
| $54 | – | 2 | -10% |
0
%
| 9 Oct ‘25 3 months ago |
|
|
|
Buy
Maintained
| $28 |
403%
upside
| 2 | -24% |
0
%
| 2 Oct ‘25 3 months ago |
|
|
|
Buy
Maintained
| $20 |
307%
upside
| 1 | -16% |
0
%
| 30 Sep ‘25 3 months ago |
|
|
|
Buy
Maintained
| $62 |
127%
upside
| 3 | +12% |
0
%
| 17 Sep ‘25 3 months ago |
|
|
|
Hold
Downgraded
| $107 | – | 2 | +46% |
0
%
| 9 Jul ‘25 6 months ago |
|
|
|
Buy
Maintained
| $47 |
32%
upside
| 2 | +54% |
0
%
| 10 Apr ‘25 9 months ago |
|
|
|
Buy
Maintained
| $9 |
547%
upside
| 1 | -5.4% |
0
%
| 26 Feb ‘25 10 months ago |
|
|
|
Hold
Downgraded
| $4 |
205%
upside
| 1 | – |
–
| 10 Feb ‘25 11 months ago |
|